Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc

Analysts see at least 10% upside in dividend aristocrat stocks PepsiCo ($PEP) and Medtronic ($MDT). This matters as the companies have ex-dividend ...

Dividend Aristocrat Stocks PEP and MDT Attract 10%+ Upside Targets Ahead of Key September Dates

Medtronic ($MDT) announced an update on their ongoing clinical study. The PERSIST addendum study, officially titled “Post Market Evaluation of Real...

Medtronic’s PERSIST Study Builds Real-World Evidence for Inceptiv SCS and Investor Confidence

Analysts have been eager to weigh in on the Healthcare sector with new ratings on United Therapeutics (UTHR) and Medtronic (MDT). United Therapeuti...

Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Guardant Health (GH) with bullis...

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

Here’s a look at today’s key earnings reports from major publicly traded companies. An especially interesting report to keep an eye on will be Cybe...

Palo Alto Networks (PANW) Among the Stocks Reporting Earnings Today – September 1, 2026

Medtronic will report its Fiscal Q1 2027 earnings before markets open on Tuesday and the shares will likely fall after that report.


Will Medtronic Stock (MDT) Rise or Fall After Earnings?

U.S. stocks finished Friday lower after Federal Reserve Chair Kevin Warsh warned that inflation remains too high and suggested interest rate hikes ...

The Week That Was, The Week Ahead: Macro and Markets, August 30

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Healthequity (HQY) with bullish ...

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and Healthequity (HQY)

Zoomd Technologies ( ($TSE:ZOMD) ) has shared an announcement. Zoomd Technologies said it will release its second-quarter 2026 financial results on...

Zoomd Technologies Sets Date for Q2 2026 Results and Investor Call

Shares in medical technology group Boston Scientific ($BSX) dipped over 3% in pre-market trading after it revealed it had been hit by a major cyber...

Boston Scientific Stock (BSX) Plunges After Global Cybersecurity Incident

MedTech Solutions S.A. ( ($PL:MDT) ) has issued an update. MedTech Solutions S.A. has secured a tender from the Samodzielny Publiczny Wojewódzki Sz...

MedTech Solutions Wins Orthopedic Implant Tender and Sets New Reporting Threshold

Citi analyst Joanne Wuensch reiterated a Buy rating on Medtronic today and set a price target of $110.00. Wuensch covers the Healthcare sector, foc...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$94.17	+1.15%	8.64M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$94.17	+1.1%	8.64M
3
4
5
6

MDT

Get Medtronic plc Data in Excel

Get Medtronic plc Data in Excel